Frost & Sullivan Supports Escom's Pharmaceutical Summit as Knowledge Partner

28th October, 2014

Asia’s pharmaceutical market outpacing every other region of the world with CAGR of 14.4% in the period 2012-2017. Pharmaceutical companies find Asia most attractive after India and China. Within the region, Indonesia, Singapore, Malaysia, Vietnam and Thailand are countries investment funds are most bullish about.

As the world’s fourth-most populous country with a fast growing economy, Indonesia is turning into an important market for pharmaceuticals. A major expansion of public healthcare will lift the nationwide spending on medical treatment. Its pharmaceutical sector has grown at 12.5% annually over the past several years and is expected to receive another boost from the rollout of general national health insurance beginning in 2014.

The Southeast Asia Pharmaceutical Market Expansion Summit will comprise of government authorities, regulators, pharma producers, consultants, international professionals and technology leaders presenting their views and insights on topics related to regulatory, market entry, new investment & development,  manufacturing and services, focusing on raising productivity and product quality. It offers you an unrivalled opportunity to develop business to government & business to business relations.

Escom is honored to announce that the global leading consulting firm, Frost & Sullivan, is supporting this international conference as Knowledge Partner. Rhenu Buller, Senior Vice President, Healthcare, Frost & Sullivan Asia Pacific, will be participating the Summit as keynote speaker and chairperson.

©2015 Escom Events. All Rights Reserved 140408